Ovid Therapeutics Reports Business Updates and Second Quarter 2024 Financial Results

Go back to Ovid Therapeutics Reports Business Updates and Second Quarter 2024 Financial Results
(NASDAQ: OVID) Delayed: 2.71 +0.02 (0.74%)
Previous Close $2.69    52 Week High
Open $2.73    52 Week Low
Day High $2.76    P/E N/A 
Day Low $2.65    EPS
Volume 1,183,520